Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neural stem cells as delivery vehicles.

Peter Kabos1, Moneeb Ehtesham, Keith L Black

  • 1Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Ste. 800E, 8631 W 3rd St, Los Angeles, CA 90048, USA.

Expert Opinion on Biological Therapy
|July 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases.

Nature communications·2026
Same author

Sex-specific retina-brain signatures link ERα/ERβ imbalance with gliosis in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

Estradiol Reprograms Microglia to Create an Immune-Suppressed Niche Permissive to Breast Cancer Brain Metastasis.

bioRxiv : the preprint server for biology·2026
Same author

Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer's disease severity.

bioRxiv : the preprint server for biology·2026
Same author

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Nature communications·2026
Same author

Retinal tauopathy as a biological indicator of Alzheimer's disease.

Neural regeneration research·2026
Same journal

Biologic modulation of ineffective erythropoiesis in thalassemia: mechanisms, clinical practice, and future targets.

Expert opinion on biological therapy·2026
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
See all related articles

Neural stem cells (NSCs) offer new hope for treating brain disorders. Their ability to migrate to damaged areas and deliver therapeutic genes presents a promising approach for central nervous system (CNS) repair.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Biology

Background:

  • The adult mammalian central nervous system (CNS) was long considered incapable of self-repair.
  • The discovery of neural stem cells (NSCs) challenges this view, revealing their potential role in brain repair.
  • NSCs can be isolated, expanded, genetically engineered, and transplanted for therapeutic purposes.

Purpose of the Study:

  • To review recent preclinical advances in utilizing NSCs for therapeutic product delivery.
  • To highlight the migratory potential and pathology-homing abilities of NSCs in the nervous system.
  • To explore the application of NSCs in treating neurological disorders.

Main Methods:

  • Review of preclinical research on neural stem cell applications.

Related Experiment Videos

  • Analysis of NSC migratory properties and tropism to brain pathology.
  • Evaluation of gene delivery strategies using genetically engineered NSCs.

    • Main Results:

    • NSCs possess significant migratory ability and can home to sites of brain pathology.
    • Genetically engineered NSCs can deliver therapeutic gene products to specific CNS locations.
    • This targeted delivery maximizes therapeutic efficiency while minimizing off-target effects.

    Conclusions:

    • Neural stem cells represent a powerful tool for treating both diffuse and localized neurological disorders.
    • Their inherent migratory and differentiation capabilities, combined with genetic engineering, offer a novel therapeutic strategy.
    • Further preclinical advances underscore the potential of NSCs for CNS repair and targeted gene therapy.